Pneumonia News and Research

Latest Pneumonia News and Research

GENOMICA is developing new Wuhan coronavirus diagnostic kit

GENOMICA, a wholly owned company of PharmaMar Group, is developing a kit to reliably detect and identify the new virus known as "Wuhan pneumonia" (coronavirus 2019-nCoV).

31 Jan 2020

Coronavirus outbreak now a global health emergency says WHO

The Wuhan coronavirus or 2019-nCoV outbreak continues to spread in mainland China and in more than a dozen countries. In the last 24 hours, 42 had succumbed to the infection, making the death toll hit 213, with 9,692 confirmed cases, prompting the World Health Organization (WHO) to declare the coronavirus outbreak a global health emergency.

30 Jan 2020

Scientists reveal clinical features of Wuhan coronavirus patients

The Wuhan coronavirus, or the 2019-nCoV, which originated in Wuhan City in Hubei province infected more than 7,700 people with the death toll topping more than 170. China reports 38 deaths in just 24 hours, making the outbreak one of the deadliest ones the country has faced.

30 Jan 2020

Wuhan coronavirus is genetically different from human SARS, MERS-CoV, study found

The Wuhan coronavirus or the 2019-nCoV or novel coronavirus is a new human-infecting coronavirus genetically different from human SARS (Severe Acute Respiratory Syndrome), and MERS-CoV (Middle East Respiratory Syndrome), a team of scientists has found.

30 Jan 2020

Global funding for neglected disease research reaches a record high

For the first time, global funding for neglected disease R&D grew for three consecutive years, reaching a record high of more than US$4.05 billion in 2018.

30 Jan 2020

Researchers identify potential target in the fight against MERS

First identified in 2012, the MERS-coronavirus is capable of causing severe and often fatal pneumonia. There are no effective treatments for MERS.

29 Jan 2020

One-quarter of hospitalized children are prescribed antibiotics incorrectly

The overuse of antibiotics poses an increasing threat to children who develop -- or already have -- drug-resistant infections that are difficult or impossible to treat, and can cause extended hospitalization, disability and even death.

29 Jan 2020

Travel data reveals top 20 cities at risk of Wuhan coronavirus spread

The Wuhan coronavirus or 2019-N-CoV has spread across the globe, including Australia, United States, Cambodia, Canada, France, Germany, Japan, Malaysia, Nepal, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, and Vietnam.

28 Jan 2020

Successful gene therapy trial in patients with X-linked Chronic Septic Granulomatosis

American and British teams led by Drs Kohn (University of California, Los Angeles), Malech (NIH), Williams (Boston Children's) and Trasher (Great Ormond Street Institute of Child Health) published yesterday in Nature Medicine the conclusive results of a gene therapy trial conducted in the United States and Great Britain in 9 patients with X-linked Chronic Septic Granulomatosis (X-CGD), a rare and severe immune dysfunction. Six of them are free of treatment for complications generated by the disease.

28 Jan 2020

Pulmonary imaging key to diagnosing vaping-related lung damage

In 2019, the emergence of mysterious lung disease in the United States has sparked global health attention. Now named as the e-cigarette, or vaping, product use–associated lung injury (EVALI), the disease causes lung damage, which is a serious and sometimes fatal complication of vaping.

28 Jan 2020

PCORI Board of Governors approve $12.2 million to find ways to treat different health conditions

The Patient-Centered Outcomes Research Institute Board of Governors today approved $12.2 million to fund four studies comparing the most effective ways to treat a range of health conditions that impose high burdens on patients, their families and the healthcare system.

28 Jan 2020

Preterm survival rate up by 25 percent thanks to the quality improvement program

Preterm birth occurs before 37 weeks of gestation and has been tied to many complications in the infant. In Canada, the rate of survival of very preterm infants born between 28 to 32 weeks, improved by 25 percent, thanks to the national Evidence-based Practice for Improving Quality (EPIQ) program in neonatal intensive care units (NICUs) across the country.

27 Jan 2020

ECDC provides risk assessment of 2019-nCoV case importation into EU/EEA countries

On 24 January 2020, the first imported cases (3) of 2019-nCoV were identified in France. The rapid increase in the number of reported cases can be partly attributed to the ongoing improved testing protocols and epidemiological investigations of the Chinese authorities; however, since the original source remains unknown and human-to-human transmission has been documented, further cases and deaths are expected.

27 Jan 2020

Indoor dust carrying bacteria that could be harbouring antibiotic resistance

Bacteria enter our homes on our the skin, or through the air, but once inside they may transfer antibiotic resistance traits to other bacteria residing in the indoor dust, a possibility raised by a new study

26 Jan 2020

Something far deadlier than the Wuhan virus lurks near you

There's a deadly virus spreading from state to state. It preys on the most vulnerable, striking the sick and the old without mercy. In just the past few months, it has claimed the lives of at least 39 children.

24 Jan 2020

Mycoplasma in Cell Culture: Fighting Back with Rapid Detection Kits

In this interview, discussing the effects of mycoplasma contamination on cell cultures and the development of rapid detection kits that provide answers in just thirty minutes.

From Gold Biotechnology, Inc. 24 Jan 2020

Infectious disease expert explains about Wuhan coronavirus

A new coronavirus virus, likely first transmitted to people from animals at a market in the Chinese city of Wuhan, is making international headlines as disease detectives work to uncover what it is, how it's transmitted, and how deadly the virus actually is.

24 Jan 2020

NIAID officials describe steps to control coronavirus that recently originated in China

The new cluster of viral pneumonia cases originating in Wuhan, China, marks the third time in 20 years that a member of the large family of coronaviruses (CoVs) has jumped from animals to humans and sparked an outbreak.

24 Jan 2020

Lung microbes could help predict outcomes in the seriously ill

A new study published in the American Journal of Respiratory and Critical Care Medicine shows that recording the way the organisms living within the lungs change in type and numbers could reflect the response of the critically ill patient to medical care. Though changes in the lung microbiome have been known to exist even before this study, this research shows the clinical importance of this test.

23 Jan 2020

Being exposed to diesel exhaust particles raises pneumococcal disease risk

Air pollution is a long-standing global problem, which is responsible for 7 million deaths each year, with 7 percent of these attributed to pneumonia. A new study highlights how air pollution affects the airways making the body susceptible to developing the pneumococcal disease.

23 Jan 2020